INNOVADERM CRO IS NOW INDERO.

Join The Indero Investigator Network

Indero is all in with dermatology and rheumatology research. Make an impact on patients’ lives around the world by participating in cutting-edge clinical research, supported by Indero.

About Our Dermatology & Rheumatology Research

Indero is a dual-focus CRO for immune-mediated diseases that has been contributing to clinical research and development for over 25 years (formerly under the Innovaderm brand). We’ve supported over 500 clinical trials across over 30 indications, and can support early phase and late phase studies around the world.

We bring a unique clinical perspective to every study we run. From treating patients to collaborating with physicians, we provide the ideal level of CRO support all the way to the site level.

Dermatology Expertise

  • Atopic dermatitis
  • Psoriasis
  • Alopecia areata
  • Hidradenitis suppurativa

Rheumatology Expertise

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Systemic sclerosis 
  • Systemic lupus erythematosus

What to Expect When Partnering with Indero

Partner investigators participate in cutting-edge research and actively contribute to the advancement of novel therapies that help improve patient care. Plus, Indero gives our partners access to the latest developments in dermatology and rheumatology so you can stay up to date.

Dr. Mark Lee

Progressive Clinical Research, Texas, USA

“We know that we can always rely on them to put their central campaign expertise and advertisement knowledge within the clinical research industry to good use.”

Join Our Global Network

Indero partners with investigators across the world to advance dermatology and rheumatology research where patients need it most. Tell us about your site setting, research experience and interest, and we’ll be in touch.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.